HCM 2017* Alvaro Gonzalez Rajal
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, NSW, Australia
Presentations this author is a contributor to:
Predicting chemoresistance in lung adenocarcinoma through the analysis of drug induced signalling dynamics (#21)
12:10 PM
Jordan Hastings
Session 6: Signalling Network in Medicine